Congratulations to the BCW’s esteemed life sciences member and Hall of Fame winner Regeneron Pharmaceuticals for winning the 2025 Prix Galien USA Best Biotechnology Product Award for the groundbreaking science of Dupixent. The Galien Foundation, which acknowledges extraordinary scientific innovations that improve the human condition, presented the award on October 30 in New York City for the drug’s transformational impact on multiple rare and common allergic and atopic conditions. It is the second “Best Biotechnology Product” award for Regeneron following the 2022 recognition of Inmazeb®. “We are honored that the Galien Foundation has recognized Dupixent, which was invented by Regeneron […]